Side Branch Stent Alignment Through a Main Stent Side Hole

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional stents struggle with treating bifurcated vessels due to issues such as impaired blood flow, difficulty in accessing daughter vessels, and high rates of in-stent restenosis, particularly when deployed at or near vessel bifurcation points, and systemic drug delivery methods are ineffective for localized treatment.

Innovation Solution

A catheter system with independently operable mother and daughter vessel guidewires and balloons, allowing for precise alignment and deployment of stents in bifurcations, combined with localized drug delivery via stents, to address these challenges.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If conventional stents are deployed at vessel bifurcations to treat occlusions, then vessel support is improved, but blood flow is impeded and access to daughter vessels is blocked

Engineering Contradiction:
Improvevessel supportVSAvoidaccess to daughter vessels
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The stent is divided into multiple segments including a mother vessel portion and a daughter vessel portion, allowing each segment to be optimized for its specific function. The mother vessel portion provides structural support while the daughter vessel portion maintains patency and access to side branches.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The stent design incorporates a three-dimensional structure with struts arranged in specific patterns that create channels and spaces for blood flow in multiple directions, allowing simultaneous support of the main vessel and access to daughter vessels.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If stent cell structure size is minimized to promote coverage and prevent tissue prolapse, then vessel wall support is improved, but access for future daughter stent implantation is reduced

Engineering Contradiction:
Improveprevention of tissue prolapseVSAvoidaccess for future procedures
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

Different regions of the stent have different cell structure characteristics. The mother vessel portion has smaller cells for optimal support and tissue coverage, while the daughter vessel portion has larger cells that facilitate access and prevent jailing of future daughter stents.

Inventive Principle:
Principle #3Local quality

3Productivity

If conventional stents are used to treat bifurcations, then immediate vessel patency is achieved, but in-stent restenosis occurs at high rates

Engineering Contradiction:
Improveimmediate vessel patencyVSAvoidrestenosis prevention
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The stent is pre-coated with anti-restenosis drugs and/or bioactive agents before implantation. This preliminary preparation ensures that as soon as the stent is deployed, therapeutic substances are released to prevent intimal hyperplasia and restenosis, addressing the problem before it occurs.

Inventive Principle:
Principle #10Preliminary action

4Ease of operation

If systemic drug delivery is used to treat restenosis, then drug distribution is simplified, but localized treatment effectiveness is reduced

Engineering Contradiction:
Improvedrug delivery simplicityVSAvoidlocalized treatment effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The drug delivery function is extracted from the systemic circulation and integrated directly into the stent structure. The stent serves as a localized delivery vehicle, concentrating therapeutic agents at the treatment site rather than distributing them systemically, thereby improving local effectiveness.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The stent performs multiple functions simultaneously: mechanical support of the vessel wall, prevention of restenosis through drug delivery, and maintenance of blood flow. This multi-functionality eliminates the need for separate systemic drug therapy while achieving both structural and pharmacological goals.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260026950A1Side branch stenting for treating a bifurcation
Publication Date: 2026.01.29 ADVANCED BIFURCATION SYST INC
  • US20260026950A1 patent drawing
  • US20260026950A1 patent drawing
  • US20260026950A1 patent drawing

AI summary

The present disclosure relates to a method for deploying a side branch stent in a bifurcated vessel that already contains a pre-existing main branch stent. The method involves inserting guide wires into both the main and side branches, and advancing a dual catheter delivery system, where only the side branch catheter carries the side branch stent. The system is retracted to position behind a side hole of the pre-existing stent, and guide wires are adjusted to reduce crossing. The catheters are aligned using marker bands and advanced towards the bifurcation until a specific tension is achieved. A balloon on the side branch catheter is then inflated to deploy the side branch stent through the side hole. This is followed by a kissing balloon inflation for optimal stent apposition. The catheters are then deflated and removed, leaving the stents aligned without gaps, ensuring effective treatment of the bifurcation.